These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

676 related articles for article (PubMed ID: 29112693)

  • 1. Comparison of two cash transfer strategies to prevent catastrophic costs for poor tuberculosis-affected households in low- and middle-income countries: An economic modelling study.
    Rudgard WE; Evans CA; Sweeney S; Wingfield T; Lönnroth K; Barreira D; Boccia D
    PLoS Med; 2017 Nov; 14(11):e1002418. PubMed ID: 29112693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The economic effects of supporting tuberculosis-affected households in Peru.
    Wingfield T; Tovar MA; Huff D; Boccia D; Montoya R; Ramos E; Lewis JJ; Gilman RH; Evans CA
    Eur Respir J; 2016 Nov; 48(5):1396-1410. PubMed ID: 27660507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with catastrophic total costs due to tuberculosis under a designated hospital service model: a cross-sectional study in China.
    Yang T; Chen T; Che Y; Chen Q; Bo D
    BMC Public Health; 2020 Jun; 20(1):1009. PubMed ID: 32586305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catastrophic costs among tuberculosis-affected households in Zimbabwe: A national health facility-based survey.
    Timire C; Ngwenya M; Chirenda J; Metcalfe JZ; Kranzer K; Pedrazzoli D; Takarinda KC; Nguhiu P; Madzingaidzo G; Ndlovu K; Mapuranga T; Cornell M; Sandy C
    Trop Med Int Health; 2021 Oct; 26(10):1248-1255. PubMed ID: 34192392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of financial support on reducing the incidence of catastrophic costs among tuberculosis-affected households in Indonesia: eight simulated scenarios.
    Fuady A; Houweling TAJ; Mansyur M; Burhan E; Richardus JH
    Infect Dis Poverty; 2019 Feb; 8(1):10. PubMed ID: 30709415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining catastrophic costs and comparing their importance for adverse tuberculosis outcome with multi-drug resistance: a prospective cohort study, Peru.
    Wingfield T; Boccia D; Tovar M; Gavino A; Zevallos K; Montoya R; Lönnroth K; Evans CA
    PLoS Med; 2014 Jul; 11(7):e1001675. PubMed ID: 25025331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The economic burden of households affected by tuberculosis in Brazil: First national survey results, 2019-2021.
    Noia Maciel EL; Negri LDSA; Guidoni LM; Fregona GC; Johansen FDC; Sanchez MN; Moreira ADSR; Diaz-Quijano FA; Tonini M; Zandonade E; Ershova J; Nguhiu P; Baena IG
    PLoS One; 2023; 18(12):e0287961. PubMed ID: 38091306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond pills and tests: addressing the social determinants of tuberculosis.
    Wingfield T; Tovar MA; Huff D; Boccia D; Saunders MJ; Datta S; Montoya R; Ramos E; Lewis JJ; Gilman RH; Evans C
    Clin Med (Lond); 2016 Dec; 16(Suppl 6):s79-s91. PubMed ID: 27956446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catastrophic total costs in tuberculosis-affected households and their determinants since Indonesia's implementation of universal health coverage.
    Fuady A; Houweling TAJ; Mansyur M; Richardus JH
    Infect Dis Poverty; 2018 Jan; 7(1):3. PubMed ID: 29325589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expansion of social protection is necessary towards zero catastrophic costs due to TB: The first national TB patient cost survey in the Philippines.
    Florentino JL; Arao RML; Garfin AMC; Gaviola DMG; Tan CR; Yadav RP; Hiatt T; Morishita F; Siroka A; Yamanaka T; Nishikiori N
    PLoS One; 2022; 17(2):e0264689. PubMed ID: 35226705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catastrophic costs incurred by tuberculosis affected households from Thailand's first national tuberculosis patient cost survey.
    Youngkong S; Kamolwat P; Wongrot P; Thavorncharoensap M; Chaikledkaew U; Nateniyom S; Pungrassami P; Praditsitthikorn N; Mahasirimongkol S; Jittikoon J; Nishikiori N; Baena IG; Yamanaka T
    Sci Rep; 2024 May; 14(1):11205. PubMed ID: 38755216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costs incurred by patients with drug-susceptible pulmonary tuberculosis in semi-urban and rural settings of Western India.
    Rupani MP; Cattamanchi A; Shete PB; Vollmer WM; Basu S; Dave JD
    Infect Dis Poverty; 2020 Oct; 9(1):144. PubMed ID: 33076969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic burden of tuberculosis in Tanzania: a national survey of costs faced by tuberculosis-affected households.
    Kilale AM; Pantoja A; Jani B; Range N; Ngowi BJ; Makasi C; Majaha M; Manga CD; Haule S; Wilfred A; Hilary P; Mahamba V; Nkiligi E; Muhandiki W; Matechi E; Mutayoba B; Nishkiori N; Ershova J
    BMC Public Health; 2022 Mar; 22(1):600. PubMed ID: 35351063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review.
    Laurence YV; Griffiths UK; Vassall A
    Pharmacoeconomics; 2015 Sep; 33(9):939-55. PubMed ID: 25939501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cash transfer and microfinance interventions for tuberculosis control: review of the impact evidence and policy implications.
    Boccia D; Hargreaves J; Lönnroth K; Jaramillo E; Weiss J; Uplekar M; Porter JDH; Evans CA
    Int J Tuberc Lung Dis; 2011 Jun; 15 Suppl 2(Suppl 2):37-49. PubMed ID: 21740658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The economic burden of TB diagnosis and treatment in South Africa.
    Foster N; Vassall A; Cleary S; Cunnama L; Churchyard G; Sinanovic E
    Soc Sci Med; 2015 Apr; 130():42-50. PubMed ID: 25681713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How affordable is TB care? Findings from a nationwide TB patient cost survey in Ghana.
    Pedrazzoli D; Siroka A; Boccia D; Bonsu F; Nartey K; Houben R; Borghi J
    Trop Med Int Health; 2018 Aug; 23(8):870-878. PubMed ID: 29851223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Innovative Socio-economic Interventions Against Tuberculosis (ISIAT) project: an operational assessment.
    Rocha C; Montoya R; Zevallos K; Curatola A; Ynga W; Franco J; Fernandez F; Becerra N; Sabaduche M; Tovar MA; Ramos E; Tapley A; Allen NR; Onifade DA; Acosta CD; Maritz M; Concha DF; Schumacher SG; Evans CA
    Int J Tuberc Lung Dis; 2011 Jun; 15 Suppl 2(Suppl 2):50-57. PubMed ID: 21740659
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 34.